Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03763604
Title Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

breast cancer

Therapies

Abemaciclib

Age Groups: adult | senior
Covered Countries ITA | ESP | CAN


No variant requirements are available.